97
Views
20
CrossRef citations to date
0
Altmetric
Original Research

Differential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patients

, , , , , & show all
Pages 745-757 | Published online: 10 Apr 2015

References

  • TsiligianniIKocksJTzanakisNSiafakasNvan der MolenTFactors that influence disease-specific quality of life or health status in patients with COPD: a review and meta-analysis of Pearson correlationsPrim Care Respir J201120325726821472192
  • JonesPWHealth status measurement in chronic obstructive pulmonary diseaseThorax2001561188088711641515
  • JonesPWQuirkFHBaveystockCMThe St George’s Respiratory QuestionnaireRespir Med199185Suppl B2531 discussion 33–371759018
  • JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
  • VestboJEdwardsLDScanlonPDECLIPSE InvestigatorsChanges in forced expiratory volume in 1 second over time in COPDN Engl J Med2011365131184119221991892
  • NishimuraMMakitaHNagaiKHokkaido COPD Cohort Study InvestigatorsAnnual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary diseaseAm J Respir Crit Care Med20121851445222016444
  • CasanovaCde TorresJPAguirre-JaímeAThe progression of chronic obstructive pulmonary disease is heterogeneous: the experience of the BODE cohortAm J Respir Crit Care Med201118491015102121836135
  • OgaTNishimuraKTsukinoMSatoSHajiroTMishimaMLongitudinal deteriorations in patient reported outcomes in patients with COPDRespir Med2007101114615316713225
  • KestenSCelliBDecramerMLiuDTashkinDAdverse health consequences in COPD patients with rapid decline in FEV1 – evidence from the UPLIFT trialRespir Res20111212921955733
  • FabbriLPauwelsRAHurdSSGOLD Scientific CommitteeGlobal strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary updated 2003COPD200411105141 discussion 103–10416997745
  • DonaldsonGCWedzichaJACOPD exacerbations. 1: EpidemiologyThorax200661216416816443707
  • SuzukiMMakitaHItoYMNagaiKKonnoSNishimuraMHokkaido COPD Cohort Study InvestigatorsClinical features and determinants of COPD exacerbation in the Hokkaido COPD cohort studyEur Respir J20144351289129724232696
  • LittleRJD’AgostinoRCohenMLThe prevention and treatment of missing data in clinical trialsN Engl J Med2012367141355136023034025
  • YorganciogluAHavlucuYCelikPDincGSakaARelation between quality of life and morbidity and mortality in COPD patients: Two-year follow-up studyCOPD20107424825320673033
  • OgaTTsukinoMHajiroTIkedaANishimuraKAnalysis of longitudinal changes in dyspnea of patients with chronic obstructive pulmonary disease: an observational studyRespir Res2012138523006638
  • FoglioKBianchiLBrulettiGSeven-year time course of lung function, symptoms, health-related quality of life, and exercise tolerance in COPD patients undergoing pulmonary rehabilitation programsRespir Med200710191961197017531455
  • TashkinDPCelliBKestenSLystigTMehraSDecramerMLong-term efficacy of tiotropium in relation to smoking status in the UPLIFT trialEur Respir J201035228729419717481
  • FerrariRTanniSECaramLMNavesCRGodoyIPredictors of health status do not change over three-year periods and exacerbation makes difference in chronic obstructive pulmonary diseaseHealth Qual Life Outcomes2011911222152155
  • TroostersTCelliBLystigTUplift InvestigatorsTiotropium as a first maintenance drug in COPD: secondary analysis of the UPLIFT trialEur Respir J2010361657320185426
  • JonesPWAndersonJACalverleyPMTORCH investigatorsHealth status in the TORCH study of COPD: treatment efficacy and other determinants of changeRespir Res2011127121627828
  • SpencerSCalverleyPMSherwood BurgePJonesPWISOLDE Study GroupInhaled Steroids in Obstructive Lung Disease. Health status deterioration in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2001163112212811208636
  • WilkeSSpruitMAWoutersEFScholsJMFranssenFMJanssenDJDeterminants of 1-year changes in disease-specific health status in patients with advanced chronic obstructive pulmonary disease: a 1-year observational studyInt J Nurs Pract Epub2014326
  • WestwoodMBourbeauJJonesPWCerulliACapkun-NiggliGWorthyGRelationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic reviewRespir Res2011124021477298
  • DonohueJFFogartyCLötvallJINHANCE Study InvestigatorsOnce-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropiumAm J Respir Crit Care Med2010182215516220463178
  • MonteagudoMRodríguez-BlancoTLlagosteraMFactors associated with changes in quality of life of COPD patients: a prospective study in primary careRespir Med2013107101589159723786889
  • JonesPWSt George’s Respiratory Questionnaire: MCIDCOPD200521757917136966
  • JonesPWBeehKMChapmanKRDecramerMMahlerDAWedzichaJAMinimal clinically important differences in pharmacological trialsAm J Respir Crit Care Med2014189325025524383418
  • JonesPWMahlerDAGaleROwenRKramerBProfiling the effects of indacaterol on dyspnoea and health status in patients with COPDRespir Med2011105689289921397482
  • LareauSCBreslinEHMeekPMFunctional status instruments: outcome measure in the evaluation of patients with chronic obstructive pulmonary diseaseHeart Lung19962532122248635922